|
Feb 24
|
Alnylam Pharmaceuticals (ALNY): Among the Oversold Biotech Stocks to Buy Now
|
|
Feb 18
|
SNY and REGN's Dupixent sBLA for Skin Disease Gets FDA's Priority Tag
|
|
Feb 14
|
Alnylam Q4 Earnings Beat Estimates, Product Revenues Rise Y/Y
|
|
Feb 14
|
Alnylam Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 14
|
Alnylam Pharmaceuticals Inc (ALNY) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
|
|
Feb 14
|
Q4 2024 Alnylam Pharmaceuticals Inc Earnings Call
|
|
Feb 13
|
Alnylam (ALNY) Reports Q4 Earnings: What Key Metrics Have to Say
|
|
Feb 13
|
Alnylam Pharmaceuticals (ALNY) Beats Q4 Earnings and Revenue Estimates
|
|
Feb 13
|
Alnylam: Q4 Earnings Snapshot
|
|
Feb 13
|
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Period Progress
|
|
Feb 12
|
Biogen's Q4 Earnings & Sales Beat, 2025 EPS Guidance Disappoints
|
|
Feb 11
|
ILMN vs. ALNY: Which Stock Is the Better Value Option?
|
|
Feb 10
|
Will These 5 Biotech Bigwig Stocks Surpass Q4 Earnings Forecast?
|
|
Feb 10
|
Ahead of Alnylam (ALNY) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics
|
|
Oct 2
|
Here's Why You Should Add ALNY Stock to Your Portfolio Right Now
|
|
Oct 1
|
Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
|
|
Oct 1
|
Not Holding Alnylam Pharmaceuticals (ALNY) Hurt Fidelity Growth Strategies Fund’s Performance
|
|
Sep 29
|
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024
|
|
Sep 26
|
Alnylam to Webcast TTR Investor Day
|
|
Aug 30
|
Why IBD 50's Alnylam Just Reversed Its 50% Gain — And BridgeBio Surged
|